Quinn, J. A., Desjardins, A., Reardon, D., Vredenburgh, J., Rich, J., Gururangan, S., … Friedman, H. S. (2004). Phase I trial of temozolomide (Temodar) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in the treatment of recurrent or progressive cerebral anaplastic gliomas. In NEURO-ONCOLOGY (Vol. 6, pp. 380–380). Toronto, CANADA: DUKE UNIV PRESS.

Quinn, J. A., A. Desjardins, D. Reardon, J. Vredenburgh, J. Rich, S. Gururangan, A. Friedman, et al. “Phase I trial of temozolomide (Temodar) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in the treatment of recurrent or progressive cerebral anaplastic gliomas.” In NEURO-ONCOLOGY, 6:380–380. DUKE UNIV PRESS, 2004.

Quinn JA, Desjardins A, Reardon D, Vredenburgh J, Rich J, Gururangan S, et al. Phase I trial of temozolomide (Temodar) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in the treatment of recurrent or progressive cerebral anaplastic gliomas. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 380–380.

Quinn, J. A., et al. “Phase I trial of temozolomide (Temodar) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in the treatment of recurrent or progressive cerebral anaplastic gliomas.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 380–380.

Quinn JA, Desjardins A, Reardon D, Vredenburgh J, Rich J, Gururangan S, Friedman A, Sampson J, Provenzale J, McLendon R, Herndon J, Dolan ME, Badruddoja M, Walker A, Tourt-Uhlig S, Friedman HS. Phase I trial of temozolomide (Temodar) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in the treatment of recurrent or progressive cerebral anaplastic gliomas. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 380–380.